BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 51)

UTI treatment: FDA grants Fast Track Designation to investigational antibiotic, CARBAVANCE

By

The Medicines Company today announced that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track Designation to the investigational agent CARBAVANCE® (meropenem-vaborbactam) for the treatment...

CLL treatment, Venclexta receives FDA approval

By

The U.S. Food and Drug Administration today approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p deletion...

Genital herpes treatment: Genocea Biosciences announce data from Phase II trials

By

Cambridge, Mass. biopharmaceutical company, Genocea Biosciences, Inc., announced this week positive 12 month efficacy data from its Phase 2 dose optimization trial evaluating GEN-003 for the treatment...

Staph

Fighting antibiotic-resistant infections with potent new nanodrug

By

A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting...

ticks

Lyme disease: Northeastern University researchers investigate four promising new treatments

By

A mouse study of a reg­imen that erad­i­cated the bac­terium in the test tube, set­ting the stage for human trials; antibi­otic cock­tails using existing drugs; strate­gies to dis­cover new drugs...

Staphylococcus aureus skin infections: Many fail to complete antibiotics resulting in new infections

By

In the first study of its kind, researchers found patients with S. aureus skin and soft tissue infections took, on average, just 57% of their prescribed antibiotic doses after leaving the hospital, resulting...

TB drug, Onecure, recalled in Philippines due to ‘insufficient amount of Rifampicin’

By

The Philippines Food and Drug Administration (FDA) announced the recall of the anti-tuberculosis drug, Onecure, after one component of the drug failed specifications. Onecure, which is manufactured by...

Leishmaniasis drug, Impavido, gets FDA nod

By

The U.S. Food and Drug Administration recently approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted...

Asthma drug, Cinqair, receives FDA approval

By

The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair...

Psoriasis drug, Taltz, gets FDA approval

By

The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and...